Funding

Healome Therapeutics

United Kingdom · Biotech · Healthtech · Enterprise software

Develops proprietary eye-drop matrix technology for ocular surface diseases

Visit healometx.comFunding history

Funding history

1 round · 1 with disclosed amounts
AnnouncedRoundAmountInvestors
Seed£2MCure EB — Role not disclosedDEBRA Research — Role not disclosedEmpirical Ventures — Role not disclosedOshen Bio — Role not disclosedSFC Capital — Role not disclosed

Investors

Cure EBSeedDEBRA ResearchSeedEmpirical VenturesSeedOshen BioSeedSFC CapitalSeed

Coverage

Jul 7, 2026Healome Therapeutics · Seed

Similar companies

Guoke Brain-ComputerBeijing startup developing non-invasive wearable brain-computer interfaces that combine brain-signal detection, decoding and neural modulation.Undisclosed · Seed
Knowledge WorkTokyo software company developing sales AI agents, an agent operating platform and consulting services for enterprise sales teams.¥4.8B · Series C debt second close
Pathos AIClinical-stage drug developer using AI to select therapeutic assets and guide oncology trials.$237M · Series E
Sourceshealometx.com ↗